To Kill a Microglia: A Case for CSF1R Inhibitors
Authors:
- 10 August 2020
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 41 (9) , 771-784
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Alzheimer's Association
This publication has 129 references indexed in Scilit:
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s diseaseMolecular Neurodegeneration, 2013
- Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cellsProceedings of the National Academy of Sciences, 2012
- Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent MannerNeuron, 2012
- Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory DeficitsPLOS ONE, 2011
- An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammationBlood, 2010
- Microglial Interactions with Synapses Are Modulated by Visual ExperiencePLOS Biology, 2010
- Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cellsJournal of Leukocyte Biology, 2010
- Dual Roles for Perivascular Macrophages in Immune-to-Brain SignalingNeuron, 2010
- Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2006
- The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1Cell, 1985